Gene Editing Offers Hope for Africa’s Sickle Cell Patients — But Price Tag Makes Cure a Distant Dream
Revolutionary CRISPR-based sickle cell therapies are raising unprecedented hope across Africa — the continent that carries 85 percent of the global disease burden — even as the $2.2 million price tag places cures forever out of reach for most patients.